Modified Serum ALP Values and Timing of Apparition of Knee Epiphyseal Ossification Centers in Preterm Infants with Cholestasis and Risk of Concomitant Metabolic Bone Disease of Prematurity

Autor: Pablo Docio, Luis de la Rubia, María T. García-Unzueta, Isabel de las Cuevas, María J Cabero-Perez, Domingo González-Lamuño, Bernardo A. Lavín-Gómez, Sandra Llorente-Pelayo
Přispěvatelé: Universidad de Cantabria
Rok vydání: 2020
Předmět:
Male
Time Factors
Epiphyseal Ossification Centers
Metabolic Bone Disease
Infant
Premature
Diseases

Gastroenterology
Cohort Studies
0302 clinical medicine
Osteogenesis
rickets
Growth Plate
Prospective Studies
030212 general & internal medicine
Ultrasonography
Nutrition and Dietetics
Cholestasis
musculoskeletal
neural
and ocular physiology

musculoskeletal system
Alkaline phosphatase
Biomarker (medicine)
Female
metabolic bone disease
medicine.symptom
Prematurity
alkaline phosphatase
lcsh:Nutrition. Foods and food supply
Infant
Premature

Rickets
Risk
musculoskeletal diseases
medicine.medical_specialty
lcsh:TX341-641
Sensitivity and Specificity
digestive system
Article
Metabolic bone disease
03 medical and health sciences
stomatognathic system
030225 pediatrics
Internal medicine
medicine
Animals
Humans
Knee
Retrospective Studies
Bone Specific Alkaline Phosphatase
Ossification
business.industry
Osteopenia
prematurity
Infant
Reproducibility of Results
medicine.disease
Alkaline Phosphatase
Bone Diseases
Metabolic

osteopenia
Spain
Concomitant
business
cholestasis
Biomarkers
Food Science
Zdroj: Nutrients . 2020 Dec 17;12(12):3854.
UCrea Repositorio Abierto de la Universidad de Cantabria
instname
Nutrients, Vol 12, Iss 3854, p 3854 (2020)
Nutrients
Volume 12
Issue 12
Universidad de Cantabria (UC)
Popis: The usefulness of serum alkaline phosphatase (ALP) and phosphorous in screening and monitoring of metabolic bone disease of prematurity (MBDP) still has some limitations, especially in preterm infants with concomitant conditions such as cholestasis. We aimed to assess a modification of serum ALP (M-ALP) as a biomarker for MBDP in preterm infants, and the use of ultrasound monitoring for the apparition of knee ossification centers as marker of bone mineralization. Biochemical and clinical registers were taken from 94 preterm newborns <
32 weeks. A significant correlation existed between serum ALP and direct bilirubin (DB), expressed by the regression equation: M-ALP (IU/L) = 302.1 + 96.9 (DB (mg/dL)). The ratio ALP/M-ALP >
1 was demonstrated to be more specific (87.5%) in the diagnosis of MBDP than the cut-off value of serum ALP >
500 IU/L (62.5%). ALP/M-ALP >
1 showed 100% sensitivity and specificity for the diagnosis of MBDP, and a good correlation with specific bone ALP (B-ALP). Patients with the knee nucleus by post-menstrual week 37 had lower B-ALP compared to patients with no nucleus, and no patients with MBDP presented the nucleus by the 40th week. In the absence of reliable specific B-ALP, reinterpreting serum ALP values by M-ALP plus monitoring of knee ossification centers contribute to better management of MBDP in preterm infants with cholestasis.
Databáze: OpenAIRE